115 related articles for article (PubMed ID: 12082528)
1. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis.
Fest T; Mougey V; Dalstein V; Hagerty M; Milette D; Silva S; Mai S
Oncogene; 2002 May; 21(19):2981-90. PubMed ID: 12082528
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein.
Fest T; Guffei A; Williams G; Silva S; Mai S
Oncogene; 2005 Apr; 24(18):2944-53. PubMed ID: 15735723
[TBL] [Abstract][Full Text] [Related]
3. Telomeric aggregates and end-to-end chromosomal fusions require myc box II.
Caporali A; Wark L; Vermolen BJ; Garini Y; Mai S
Oncogene; 2007 Mar; 26(10):1398-406. PubMed ID: 16953226
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability and apoptosis are frequent in p53 deficient young mice.
Fukasawa K; Wiener F; Vande Woude GF; Mai S
Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
[TBL] [Abstract][Full Text] [Related]
5. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.
Kuschak TI; Kuschak BC; Taylor CL; Wright JA; Wiener F; Mai S
Oncogene; 2002 Jan; 21(6):909-20. PubMed ID: 11840336
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
8. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
Packham G; Porter CW; Cleveland JL
Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
[TBL] [Abstract][Full Text] [Related]
9. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
[TBL] [Abstract][Full Text] [Related]
10. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
[TBL] [Abstract][Full Text] [Related]
12. C-myc overexpression and p53 loss cooperate to promote genomic instability.
Yin XY; Grove L; Datta NS; Long MW; Prochownik EV
Oncogene; 1999 Feb; 18(5):1177-84. PubMed ID: 10022123
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
[TBL] [Abstract][Full Text] [Related]
14. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
15. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells.
Chen JP; Chen L; Leek J; Lin C
Eur J Clin Invest; 2006 Jan; 36(1):49-57. PubMed ID: 16403010
[TBL] [Abstract][Full Text] [Related]
16. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
Baena E; Ortiz M; Martínez-A C; de Alborán IM
Exp Hematol; 2007 Sep; 35(9):1333-43. PubMed ID: 17637497
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
18. c-MYC impairs immunogenicity of human B cells.
Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
[TBL] [Abstract][Full Text] [Related]
19. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
20. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]